Premium
Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in the race to acquire a little over 10 per cent stake in Ahmedabad-based Intas Pharmaceuticals from existing private equity investor ChrysCapital for approximately Rs 840 crore, sources close to the deal told VCCircle.The deal, which would see ChrysCap ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
